23401344|t|Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
23401344|a|Although many post-mortem studies have found evidence of central insulin resistance in Alzheimer's disease (AD) patients, results on changes of central insulin-like growth factor-1 (IGF-1) signaling in the pathological process of AD remain controversial. In the present study, we observed the activation states of IGF-1 downstream signaling in brain slices of transgenic mice carrying APPswe/PS1dE9 mutations (APP/PS1 mice) at both early and late stages (ex vivo) and further investigated the involvement of oligomeric beta-amyloid (Abeta) and Abeta-enriched culture medium (CM) on IGF-1 sensitivity employing neuronal models (in vitro). In 6- and 18-month-old APP/PS1 mice, the phosphorylations of IGF-1 receptor (IGF-1R) and Akt in response to IGF-1 stimulation were significantly reduced in the hippocampal and cortical slices, whereas IGF-1R protein expression and mRNA levels of IGF-1 and IGF-1R in the hippocampal slices were significantly higher than that in wild-type mice. In agreement with these results, reduced IGF-1 sensitivity was verified in APP and PS1 double stably transfected CHO cells; moreover, IGF-1 stimulated phosphorylations of IGF-1R and Akt were also markedly weakened by oligomeric Abeta or Abeta-enriched CM posttreatment in CHO cells without APP/PS1-transfected (K1 cells) and primary hippocampal neurons. These observations indicate that the impaired central IGF-1 sensitivity at early and late stages of APP/PS1 transgenic mice might be attributable, at least partially, to the overproduced Abeta, especially the oligomeric Abeta. These findings may shed new light on the mechanisms underlying the defective IGF-1 signaling in AD pathogenesis and provide important clues for AD drug discovery.
23401344	24	52	insulin-like growth factor-1	Gene	16000
23401344	72	75	PS1	Gene	19164
23401344	87	91	mice	Species	10090
23401344	178	196	insulin resistance	Disease	MESH:D007333
23401344	200	219	Alzheimer's disease	Disease	MESH:D000544
23401344	221	223	AD	Disease	MESH:D000544
23401344	225	233	patients	Species	9606
23401344	265	293	insulin-like growth factor-1	Gene	16000
23401344	295	300	IGF-1	Gene	16000
23401344	343	345	AD	Disease	MESH:D000544
23401344	427	432	IGF-1	Gene	16000
23401344	484	488	mice	Species	10090
23401344	527	530	PS1	Gene	19164
23401344	531	535	mice	Species	10090
23401344	646	651	Abeta	Gene	11820
23401344	657	662	Abeta	Gene	11820
23401344	695	700	IGF-1	Gene	16000
23401344	778	781	PS1	Gene	19164
23401344	782	786	mice	Species	10090
23401344	812	826	IGF-1 receptor	Gene	16001
23401344	828	834	IGF-1R	Gene	16001
23401344	840	843	Akt	Gene	11651
23401344	859	864	IGF-1	Gene	16000
23401344	952	958	IGF-1R	Gene	16001
23401344	997	1002	IGF-1	Gene	16000
23401344	1007	1013	IGF-1R	Gene	16001
23401344	1089	1093	mice	Species	10090
23401344	1136	1141	IGF-1	Gene	16000
23401344	1178	1181	PS1	Gene	19164
23401344	1208	1211	CHO	CellLine	CVCL:0213
23401344	1229	1234	IGF-1	Gene	100751642
23401344	1266	1272	IGF-1R	Gene	100768531
23401344	1277	1280	Akt	Gene	11651
23401344	1323	1328	Abeta	Gene	11820
23401344	1332	1337	Abeta	Gene	11820
23401344	1367	1370	CHO	CellLine	CVCL:0213
23401344	1389	1392	PS1	Gene	19164
23401344	1406	1408	K1	CellLine	CVCL:C7F1
23401344	1503	1508	IGF-1	Gene	16000
23401344	1553	1556	PS1	Gene	19164
23401344	1568	1572	mice	Species	10090
23401344	1636	1641	Abeta	Gene	11820
23401344	1669	1674	Abeta	Gene	11820
23401344	1753	1758	IGF-1	Gene	16000
23401344	1772	1774	AD	Disease	MESH:D000544
23401344	1820	1822	AD	Disease	MESH:D000544
23401344	Association	16001	19164
23401344	Negative_Correlation	11651	11820
23401344	Bind	16000	16001
23401344	Association	11820	19164
23401344	Negative_Correlation	100768531	11820
23401344	Association	100751642	100768531
23401344	Association	100751642	11651
23401344	Association	MESH:D000544	16000
23401344	Association	11651	19164
23401344	Association	100751642	11820
23401344	Association	16000	19164
23401344	Positive_Correlation	11651	16000

